Pakola Steve: insider trades.
Pakola Steve reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($718K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- PAKOLA STEVE
Companies
| Company | Relationship | Transactions |
|---|---|---|
| REGENXBIO Inc. (RGNX) | Officer · Chief Medical Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-01 | REGENXBIO Inc. | F | 7,468 | $9.69 | 205,541 | Form 4 |
| 2026-07-02 | REGENXBIO Inc. | S | 2,161 | $13.64 | 213,009 | Form 4 |
| 2026-07-02 | REGENXBIO Inc. | M | 2,161 | $7.86 | 215,170 | Form 4 |
| 2026-07-01 | REGENXBIO Inc. | S | 36,725 | $12.86 | 213,009 | Form 4 |
| 2026-07-01 | REGENXBIO Inc. | M | 36,725 | $7.86 | 249,734 | Form 4 |
| 2026-06-29 | REGENXBIO Inc. | S | 19,608 | $11.04 | 213,009 | Form 4 |
Questions
What stock did Pakola Steve buy or sell?
Pakola Steve reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($718K), across 1 company.
Is Pakola Steve the same person as other filers with this name?
This page covers SEC CIK 1700659 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/pakola-steve-1700659.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.